- Headquarters
- Foster City, California, United States · North America
- Value chain
- Research & IP(Research & design)
- What that means
- Invents and licenses: corporate and contract research, IP and technology licensing, with little production of its own.
- Founded
- 1987
- Staff
- 17,600 (2024)
- Ownership
- Listed
- Listing
- Nasdaq:GILD on Google Finance
- Website
- gilead.com
- Relevance
- High at its strongest, in Advanced Therapeutics, Vaccines & Medical Countermeasures
In 1 capability
Each capability the company is listed in, most relevant first: how experts in the field see its global relevance there, why it is listed and the source.
Biotechnology & Health Technologies · Design · listed #11 of 50
Leading antiviral developer: remdesivir (Veklury) for COVID-19, HIV regimens and the twice-yearly lenacapavir HIV prevention injection, plus the Yescarta CAR-T therapy via Kite.
Relevance: Leading antiviral developer